Palliative and Precision Medicine Treatment for Biliary Tract Cancers (BTCs)
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (31 July 2026) | Viewed by 1074
Editor
Interests: minimally invasive hepatobiliary surgery; liver transplantation; systemic treatment of biliary tract cancer
Special Issue Information
Dear Colleagues,
Biliary tract cancers (BTCs) represent a group of highly heterogeneous malignancies with poor prognosis, posing significant challenges in diagnosis and treatment. With advances in precision medicine, targeted therapies (e.g., against FGFR2 fusions, IDH1 mutations) and immunotherapies have brought new hope for patients with advanced BTC. However, integrating these cutting-edge developments effectively with palliative care to optimize patients’ quality of life and prolong survival remains a critical issue in clinical practice. This Special Issue aims to compile the latest research in the field, focusing on the application of precision medicine strategies in personalized BTC treatment and the central role of palliative care throughout disease management. We welcome original research articles, reviews, and that emphasize biomarker-guided targeted therapy, innovations in immunotherapy, symptom management, supportive care, and improvements in patient quality of life.
Dr. Xiaoyong Huang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biliary tract cancers
- precision medicine
- palliative care
- targeted therapy
- immunotherapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
